2019Clinical Lymphoma Myeloma & LeukemiaRequires access

Insights into the Genomic Evolution of Ibrutinib Resistant Clones in Waldenström’s Macroglobulinemia

Cristina Jiménez, Gloria Chan, Lian Xu, Nickolas Tsakmaklis, Amanda Kofides, Maria Demos, Jiaji Chen, Xia Liu, Maria Luisa Guerrera, Manit Munshi, Guang Yang, Jorge J. Castillo, Adrian Wiestner, Ramón García‐Sánz, Steven P. Treon, Zachary R. Hunter

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ibrutinib, Bruton's tyrosine kinase, Waldenstrom macroglobulinemia, Macroglobulinemia, Cancer research, Medicine, Tyrosine kinase, Lymphoplasmacytic Lymphoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Insights into the Genomic Evolution of Ibrutinib Resistant Clones in Waldenström’s Macroglobulinemia — Research Paper | ScholarLens